Oturum Aç
  • PRACTICAL Prostate Cancer Association Group to Investigate Cancer Associated Alterations in Genome

University of Cambridge tarafından başlatılan, Avrupa Komisyonu 7. Çerçeve Programı ve NIH tarafından desteklenen, dünya üzerinde kalıtsal prostat kanserinde prostat kanseri riski oluşturabilecek genlerin tayini çalışması yapılmaktadır. Bu çalışmaya Eczacılık Fakültesi Farmasötik Toksikoloji Anabilim Dalı’nda öğretim üyesi Yrd. Doç. Dr. Nur Özten Kandaş ülkemizi temsil etmek üzere dahil olmuştur.

PRACTICAL Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome

StudyAcronymInstitutionCountry
Stockholm 1STHM1Karolinska InstitutetSweden
Stockholm 2STHM2Karolinska InstitutetSweden
Finnish Genetic Predisposition to Prostate Cancer StudyTAMPEREUniversity of TampereFinland
TASPRAC StudyTASPRACUniversity of TasmaniaAustralia
Prostate Cancer Study in Tata Memorial Centre, Navi MumbaiTMCTata Memorial Centre, Navi MumbaiIndia
University of TorontoTorontoPrincess Margaret Hospital, TorontoCanada
Practical study of TurkeyTuPracticalBezmialem Vakif UniversityTurkey
U.K. Genetic Prostate Cancer Study and The Prostate Cancer Research Foundation StudyUKGPCSInstitute of Cancer ResearchUK
Institut fuer Humangengetik UlmULMUniversity of UlmGermany
University of Southern California – Los Angeles Prostate Cancer StudyUSCUniversity of Southern CaliforniaUSA
UTAH StudyUTAHUniversity of UtahUSA
Prostate Cancer Study in ValaisValaisHopital Cantonal Universitaire de GeneveSwitzerland
Wake Forest Baptist Medical CenterWFUBMCWake Forest University School of MedicineChina
Washington University Genetics StudyWUGSWashington University School of MedicineUSA

Bilgi için : http://practical.ccge.medschl.cam.ac.uk/